Annual EPS
-$8.25
+$1.87+18.48%
31 December 2023
Summary:
Ultragenyx Pharmaceutical annual earnings per share is currently -$8.25, with the most recent change of +$1.87 (+18.48%) on 31 December 2023. During the last 3 years, it has fallen by -$1.55 (-23.13%). RARE annual EPS is now -2448.66% below its all-time high of -$0.32, reached on 31 December 2011.RARE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.40
+$0.12+7.89%
30 September 2024
Summary:
Ultragenyx Pharmaceutical quarterly earnings per share is currently -$1.40, with the most recent change of +$0.12 (+7.89%) on 30 September 2024. Over the past year, it has increased by +$0.12 (+7.89%). RARE quarterly EPS is now -325.81% below its all-time high of $0.62, reached on 31 March 2018.RARE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$6.47
+$0.83+11.37%
30 September 2024
Summary:
Ultragenyx Pharmaceutical TTM earnings per share is currently -$6.47, with the most recent change of +$0.83 (+11.37%) on 30 September 2024. Over the past year, it has increased by +$1.86 (+22.33%). RARE TTM EPS is now -2090.25% below its all-time high of -$0.30, reached on 31 December 2012.RARE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RARE EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +7.9% | +22.3% |
| 3 y3 years | -23.1% | +21.8% | +3.6% |
| 5 y5 years | -15.9% | +13.6% | +9.1% |
RARE EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.1% | +18.5% | at high | +60.0% | at high | +36.9% |
| 5 y | 5 years | -168.7% | +18.5% | -441.5% | +60.0% | -107.4% | +36.9% |
| alltime | all time | -2448.7% | +18.5% | -325.8% | +60.0% | -2090.3% | +36.9% |
Ultragenyx Pharmaceutical EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.40(-7.9%) | -$6.47(-11.4%) |
| June 2024 | - | -$1.52(-25.1%) | -$7.30(-9.1%) |
| Mar 2024 | - | -$2.03(+33.6%) | -$8.03(-3.6%) |
| Dec 2023 | -$8.25(-18.5%) | -$1.52(-31.8%) | -$8.33(-7.1%) |
| Sept 2023 | - | -$2.23(-0.9%) | -$8.97(-12.4%) |
| June 2023 | - | -$2.25(-3.4%) | -$10.24(-0.1%) |
| Mar 2023 | - | -$2.33(+7.9%) | -$10.25(+1.4%) |
| Dec 2022 | -$10.12(+51.0%) | -$2.16(-38.3%) | -$10.11(+3.8%) |
| Sept 2022 | - | -$3.50(+54.9%) | -$9.74(+33.1%) |
| June 2022 | - | -$2.26(+3.2%) | -$7.32(+6.6%) |
| Mar 2022 | - | -$2.19(+22.3%) | -$6.87(+2.4%) |
| Dec 2021 | -$6.70(+118.2%) | -$1.79(+65.7%) | -$6.71(+26.8%) |
| Sept 2021 | - | -$1.08(-40.3%) | -$5.29(-0.9%) |
| June 2021 | - | -$1.81(-10.8%) | -$5.34(+71.2%) |
| Mar 2021 | - | -$2.03(+448.6%) | -$3.12(-0.6%) |
| Dec 2020 | -$3.07(-56.9%) | -$0.37(-67.3%) | -$3.14(-28.5%) |
| Sept 2020 | - | -$1.13(-375.6%) | -$4.39(-15.9%) |
| June 2020 | - | $0.41(-120.0%) | -$5.22(-29.0%) |
| Mar 2020 | - | -$2.05(+26.5%) | -$7.35(+3.2%) |
| Dec 2019 | -$7.12(+79.3%) | -$1.62(-17.3%) | -$7.12(-1.5%) |
| Sept 2019 | - | -$1.96(+14.0%) | -$7.23(+3.1%) |
| June 2019 | - | -$1.72(-5.5%) | -$7.01(+10.4%) |
| Mar 2019 | - | -$1.82(+5.2%) | -$6.35(+62.4%) |
| Dec 2018 | -$3.97 | -$1.73(-0.6%) | -$3.91(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.74(+64.2%) | -$4.07(-3.1%) |
| June 2018 | - | -$1.06(-271.0%) | -$4.20(-13.6%) |
| Mar 2018 | - | $0.62(-132.8%) | -$4.86(-31.6%) |
| Dec 2017 | -$7.12(+14.7%) | -$1.89(+1.1%) | -$7.11(+2.0%) |
| Sept 2017 | - | -$1.87(+8.7%) | -$6.97(+3.4%) |
| June 2017 | - | -$1.72(+5.5%) | -$6.74(+4.0%) |
| Mar 2017 | - | -$1.63(-6.9%) | -$6.48(+4.5%) |
| Dec 2016 | -$6.21(+56.8%) | -$1.75(+6.7%) | -$6.20(+5.1%) |
| Sept 2016 | - | -$1.64(+12.3%) | -$5.90(+11.5%) |
| June 2016 | - | -$1.46(+8.1%) | -$5.29(+13.5%) |
| Mar 2016 | - | -$1.35(-6.9%) | -$4.66(+18.3%) |
| Dec 2015 | -$3.96(+76.0%) | -$1.45(+40.8%) | -$3.94(+30.9%) |
| Sept 2015 | - | -$1.03(+24.1%) | -$3.01(+21.4%) |
| June 2015 | - | -$0.83(+31.7%) | -$2.48(+18.1%) |
| Mar 2015 | - | -$0.63(+21.2%) | -$2.10(-9.5%) |
| Dec 2014 | -$2.25(+30.0%) | -$0.52(+4.0%) | -$2.32(-5.0%) |
| Sept 2014 | - | -$0.50(+11.1%) | -$2.44(-1.8%) |
| June 2014 | - | -$0.45(-47.1%) | -$2.49(-0.8%) |
| Mar 2014 | - | -$0.85(+32.4%) | -$2.51(+24.5%) |
| Dec 2013 | -$1.73(+104.0%) | -$0.64(+17.6%) | -$2.01(+20.8%) |
| Sept 2013 | - | -$0.55(+16.3%) | -$1.67(+48.7%) |
| June 2013 | - | -$0.47(+32.0%) | -$1.12(+72.1%) |
| Mar 2013 | - | -$0.36(+20.4%) | -$0.65(+120.4%) |
| Dec 2012 | -$0.85(+162.0%) | -$0.30 | -$0.30 |
| Dec 2011 | -$0.32 | - | - |
FAQ
- What is Ultragenyx Pharmaceutical annual earnings per share?
- What is the all time high annual EPS for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly earnings per share?
- What is the all time high quarterly EPS for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly EPS year-on-year change?
- What is Ultragenyx Pharmaceutical TTM earnings per share?
- What is the all time high TTM EPS for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical TTM EPS year-on-year change?
What is Ultragenyx Pharmaceutical annual earnings per share?
The current annual EPS of RARE is -$8.25
What is the all time high annual EPS for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual earnings per share is -$0.32
What is Ultragenyx Pharmaceutical quarterly earnings per share?
The current quarterly EPS of RARE is -$1.40
What is the all time high quarterly EPS for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly earnings per share is $0.62
What is Ultragenyx Pharmaceutical quarterly EPS year-on-year change?
Over the past year, RARE quarterly earnings per share has changed by +$0.12 (+7.89%)
What is Ultragenyx Pharmaceutical TTM earnings per share?
The current TTM EPS of RARE is -$6.47
What is the all time high TTM EPS for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high TTM earnings per share is -$0.30
What is Ultragenyx Pharmaceutical TTM EPS year-on-year change?
Over the past year, RARE TTM earnings per share has changed by +$1.86 (+22.33%)